Table 2 Relationship between patient characteristics and EGFR mutation status

From: Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403)

 

EGFR mutation positive ( n =32)

EGFR mutation negative ( n =85)

 

Characteristics

No. of Patients

%

No. of Patients

%

P

Sex

 Male

11

34

50

59

 

 Female

21

66

35

41

<0.02

Histology

 Adenocarcinoma

31

97

66

78

 

 Nonadenocarcinoma

1

3

19

22

=0.001

Smoking status

 Never

21

66

31

36

 

 Current/former

11

34

54

64

<0.001

  1. EGFR=epidermal growth factor receptor.
Back to article page